Related Experiment Video
Updated: Mar 20, 2026
08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.6K
Decoding the immune-tumor synapse for data-driven design of next-generation immunotherapies
Imke S C van Rossum1, Annemiek B van Spriel1, Guido van Mierlo1
1Department of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
Trends in Immunology
|March 18, 2026
Summary
The immunological synapse (IS) between T cells and tumor cells is key for immunotherapy. Emerging technologies now allow detailed study of this interaction, paving the way for improved cancer treatments.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- The immunological synapse (IS) is a crucial interface between cytotoxic CD8+ T lymphocytes (CTLs) and tumor cells.
- This interaction is a primary target for immunotherapies like CAR T-cell therapy and therapeutic antibodies.
- Limited understanding of the CTL-tumor IS hinders the development of more effective cancer treatments due to its transient nature.
Purpose of the Study:
- To review how recent technological advancements enhance the characterization of the CTL-tumor IS.
- To explore the potential of these technologies in guiding the development of next-generation immunotherapies.
- To propose future research directions for technological innovation in studying the CTL-tumor IS.
Main Methods:
- Proteomics
- Transcriptomics
- High-throughput imaging
- Machine learning
Main Results:
- Emerging technologies provide unprecedented precision in investigating the complex CTL-tumor IS.
- These advancements are crucial for understanding the dynamics of T cell-mediated tumor cell killing.
- New insights into the IS structure and function are emerging from multi-omic and imaging approaches.
Conclusions:
- Technological innovations are significantly improving our understanding of the CTL-tumor IS.
- This enhanced understanding is vital for designing more potent and targeted immunotherapies.
- Continued technological development is essential for future breakthroughs in cancer immunotherapy.
Related Concept Videos
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:27Cytotoxic T Cells-mediated Immune Response
7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K